Sub-lines already sit inside the relevant operating, investing or financing total and must not be added to those totals again.
FY2022 operating receipts additionally include A$64,928 exploration proceeds, A$62,945 grants and A$18,210 other receipts. Investing includes A$177,938 investment-sale proceeds; hence its positive A$12,765 is an inflow despite the source subtotal saying “used”.
FY2023 operating receipts also include A$399,547 grants and A$26,000 other receipts. FY2024 other receipts are A$5,485; investing includes A$40,321 tenement payments and A$10,728 equipment-disposal proceeds.
FY2024 financing includes A$1.100m convertible-note cash. Its A$279,506 cash decrease plus A$16,872 adverse exchange movement explains the larger decline in closing cash.
FY2025 financing additionally includes A$100,000 option-exercise cash. The acquisition financing note is separate: its initial loan amount is not added to the published cash financing subtotal.
FY2025 also has A$13,647 other operating receipts, A$8,805 cash interest paid and A$23,203 other non-current asset payments. The July 2025 A$10m placement is outside this table.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.